- Home
- Publications
- Publication Search
- Publication Details
Title
Ovarian cancer
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 2, Issue -, Pages 16061
Publisher
Springer Nature
Online
2016-08-25
DOI
10.1038/nrdp.2016.61
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germlineBRCA1/2mutation: a multistudy analysis of response rates and safety
- (2016) U. A. Matulonis et al. ANNALS OF ONCOLOGY
- Neoadjuvant chemotherapy in ovarian cancer revisited
- (2016) S. Mahner et al. ANNALS OF ONCOLOGY
- Opportunities in immunotherapy of ovarian cancer
- (2016) G. Coukos et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type
- (2016) Leora Witkowski et al. GYNECOLOGIC ONCOLOGY
- Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases
- (2016) D. Callegaro-Filho et al. GYNECOLOGIC ONCOLOGY
- Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer
- (2016) Ronald D. Alvarez et al. GYNECOLOGIC ONCOLOGY
- Talc and ovarian cancer
- (2016) Steven A. Narod GYNECOLOGIC ONCOLOGY
- Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide
- (2016) Naveena Singh et al. GYNECOLOGIC ONCOLOGY
- Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014)
- (2016) Ari Gnanasakthy et al. JOURNAL OF CLINICAL ONCOLOGY
- Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) Jonathan A Ledermann et al. LANCET
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) Andreas du Bois et al. LANCET ONCOLOGY
- Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
- (2016) John K. Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inherited Mutations in Women With Ovarian Carcinoma
- (2016) Barbara M. Norquist et al. JAMA Oncology
- Evidence for a Dualistic Model of High-grade Serous Carcinoma
- (2015) Brooke E. Howitt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes
- (2015) Shari S. Bassuk et al. ANNALS OF EPIDEMIOLOGY
- BRCA1andBRCA2genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significance
- (2015) D. M. Eccles et al. ANNALS OF ONCOLOGY
- Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
- (2015) C M Nagle et al. BRITISH JOURNAL OF CANCER
- Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
- (2015) Joan L. Walker et al. CANCER
- Maintenance chemotherapy in the management of epithelial ovarian cancer
- (2015) Maurie Markman CANCER AND METASTASIS REVIEWS
- Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies
- (2015) Anita Koushik et al. CANCER CAUSES & CONTROL
- Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy
- (2015) Chiara Della Pepa et al. CANCER TREATMENT REVIEWS
- Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research
- (2015) Angiolo Gadducci et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- New ways to successfully target tumor vasculature in ovarian cancer
- (2015) Xiaoyun Yang et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Low-grade epithelial ovarian cancer
- (2015) Ailsa J. Oswald et al. CURRENT OPINION IN ONCOLOGY
- Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study
- (2015) Milena Sant et al. EUROPEAN JOURNAL OF CANCER
- Emerging therapies: angiogenesis inhibitors for ovarian cancer
- (2015) Amanda L Jackson et al. EXPERT OPINION ON EMERGING DRUGS
- Epithelial ovarian cancer and recreational physical activity: A review of the epidemiological literature and implications for exercise prescription
- (2015) Rikki A. Cannioto et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation — An NRG Oncology/Gynecologic Oncology Group study
- (2015) Robert L. Coleman et al. GYNECOLOGIC ONCOLOGY
- Updates and emerging therapies for rare epithelial ovarian cancers: One size no longer fits all
- (2015) Reinou S. Groen et al. GYNECOLOGIC ONCOLOGY
- Content validity of the NCCN-FACT Ovarian Symptom Index-18 (NFOSI-18)
- (2015) Sally E. Jensen et al. GYNECOLOGIC ONCOLOGY
- Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care
- (2015) Natalia Rodriguez Gómez-Hidalgo et al. GYNECOLOGIC ONCOLOGY
- Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies
- (2015) Tianyi Huang et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer in the United States: Contemporary patterns of care associated with improved survival
- (2015) William A. Cliby et al. GYNECOLOGIC ONCOLOGY
- Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type
- (2015) Kezia Gaitskell et al. INTERNATIONAL JOURNAL OF CANCER
- Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer
- (2015) Timothy R. Rebbeck et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial
- (2015) Rosalind A. Eeles et al. JOURNAL OF CLINICAL ONCOLOGY
- Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study
- (2015) Elisabeth Maritschnegg et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial
- (2015) Andres M. Poveda et al. JOURNAL OF CLINICAL ONCOLOGY
- Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development
- (2015) Clare L. Scott et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
- (2015) Usha Menon et al. JOURNAL OF CLINICAL ONCOLOGY
- Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analysis of GOG 182
- (2015) Neil S. Horowitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
- (2015) Junzo Hamanishi et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Adult Weight Gain and Adiposity-Related Cancers: A Dose-Response Meta-Analysis of Prospective Observational Studies
- (2015) NaNa Keum et al. JNCI-Journal of the National Cancer Institute
- Ovarian Cancer Risk After Salpingectomy: A Nationwide Population-Based Study
- (2015) H. Falconer et al. JNCI-Journal of the National Cancer Institute
- Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies
- (2015) LANCET
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
- (2015) Sean Kehoe et al. LANCET
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Targeting c-MYC in Platinum-Resistant Ovarian Cancer
- (2015) J. M. Reyes-Gonzalez et al. MOLECULAR CANCER THERAPEUTICS
- TP53 loss creates therapeutic vulnerability in colorectal cancer
- (2015) Yunhua Liu et al. NATURE
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Costs and Benefits of Opportunistic Salpingectomy as an Ovarian Cancer Prevention Strategy
- (2015) Janice S. Kwon et al. OBSTETRICS AND GYNECOLOGY
- Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
- (2015) Rohit Prakash et al. Cold Spring Harbor Perspectives in Biology
- Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
- (2015) Georgina L. Ryland et al. Genome Medicine
- Ovarian Cancer Risk After Salpingectomy: A Nationwide Population-Based Study
- (2015) H. Falconer et al. JNCI-Journal of the National Cancer Institute
- Adult Weight Gain and Adiposity-Related Cancers: A Dose-Response Meta-Analysis of Prospective Observational Studies
- (2015) NaNa Keum et al. JNCI-Journal of the National Cancer Institute
- Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
- (2015) Alicia A Tone et al. BMC CANCER
- Intake of dietary flavonoids and risk of epithelial ovarian cancer
- (2014) Aedín Cassidy et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention
- (2014) Jessica N. McAlpine et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Patient preferences in advanced or recurrent ovarian cancer
- (2014) Laura J. Havrilesky et al. CANCER
- Intermediate clinical endpoints: A bridge between progression-free survival and overall survival in ovarian cancer trials
- (2014) Ursula A. Matulonis et al. CANCER
- Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer
- (2014) Melissa A. Merritt et al. CANCER CAUSES & CONTROL
- New Strategies in Ovarian Cancer: Translating the Molecular Complexity of Ovarian Cancer into Treatment Advances
- (2014) J. Liu et al. CLINICAL CANCER RESEARCH
- Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee
- (2014) C. J. Paller et al. CLINICAL CANCER RESEARCH
- Immunotherapy for ovarian cancer
- (2014) Emese Zsiros et al. CURRENT OPINION IN ONCOLOGY
- Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses’ Health Studies
- (2014) Megan S. Rice et al. FERTILITY AND STERILITY
- SGO guidance document for clinical trial designs in ovarian cancer: A changing paradigm
- (2014) Thomas J. Herzog et al. GYNECOLOGIC ONCOLOGY
- Global distribution pattern of histological subtypes of epithelial ovarian cancer: A database analysis and systematic review
- (2014) Pi-Lin Sung et al. GYNECOLOGIC ONCOLOGY
- PARP inhibitors in ovarian cancer: Current status and future promise
- (2014) Joyce F. Liu et al. GYNECOLOGIC ONCOLOGY
- 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer
- (2014) David G. Mutch et al. GYNECOLOGIC ONCOLOGY
- Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer
- (2014) Martin R. Stockler et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
- (2014) Amy P.M. Finch et al. JOURNAL OF CLINICAL ONCOLOGY
- Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer
- (2014) Andreas du Bois et al. JOURNAL OF CLINICAL ONCOLOGY
- Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis
- (2014) Tara M. Friebel et al. JNCI-Journal of the National Cancer Institute
- Perineal Powder Use and Risk of Ovarian Cancer
- (2014) S. C. Houghton et al. JNCI-Journal of the National Cancer Institute
- Recommended Patient-Reported Core Set of Symptoms and Quality-of-Life Domains to Measure in Ovarian Cancer Treatment Trials
- (2014) Kristine A. Donovan et al. JNCI-Journal of the National Cancer Institute
- Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium
- (2014) B. Trabert et al. JNCI-Journal of the National Cancer Institute
- Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
- (2014) Joyce F Liu et al. LANCET ONCOLOGY
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
- (2014) Sandro Pignata et al. LANCET ONCOLOGY
- Recurrent SMARCA4 mutations in small cell carcinoma of the ovary
- (2014) Petar Jelinic et al. NATURE GENETICS
- An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma
- (2014) Maria Giuseppina Baratta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mucinous Tumors of the Ovary: Current Thoughts on Diagnosis and Management
- (2014) Jubilee Brown et al. Current Oncology Reports
- A prospective cohort study of dietary indices and incidence of epithelial ovarian cancer
- (2014) Jing Xie et al. Journal of Ovarian Research
- Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study
- (2013) V Jenkins et al. BRITISH JOURNAL OF CANCER
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
- (2013) Da Yang et al. CANCER CELL
- Genital Powder Use and Risk of Ovarian Cancer: A Pooled Analysis of 8,525 Cases and 9,859 Controls
- (2013) K. L. Terry et al. Cancer Prevention Research
- Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways
- (2013) Vijaya Galic et al. CURRENT CANCER DRUG TARGETS
- Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium
- (2013) Catherine M Olsen et al. ENDOCRINE-RELATED CANCER
- Low-grade serous carcinoma: New concepts and emerging therapies
- (2013) Ignacio Romero et al. GYNECOLOGIC ONCOLOGY
- An international assessment of ovarian cancer incidence and mortality
- (2013) Kimberly A. Lowe et al. GYNECOLOGIC ONCOLOGY
- Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy
- (2013) C.B. Powell et al. GYNECOLOGIC ONCOLOGY
- Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
- (2013) Suk-Joon Chang et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
- (2013) Thomas J. Herzog et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin
- (2013) Joanne Kotsopoulos et al. INTERNATIONAL JOURNAL OF CANCER
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum
- (2013) Jaime Prat et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways
- (2013) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Contraceptives and Risk of Ovarian Cancer and Breast Cancer Among High-Risk Women: A Systematic Review and Meta-Analysis
- (2013) Patricia G. Moorman et al. JOURNAL OF CLINICAL ONCOLOGY
- Ovarian Cancer Incidence Trends in Relation to Changing Patterns of Menopausal Hormone Therapy Use in the United States
- (2013) Hannah P. Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
- (2013) Ali Bashashati et al. JOURNAL OF PATHOLOGY
- Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer
- (2013) Christopher P Crum et al. JOURNAL OF PATHOLOGY
- The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
- (2013) Shahneen K Sandhu et al. LANCET ONCOLOGY
- Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
- (2013) Noriyuki Katsumata et al. LANCET ONCOLOGY
- Adherence to Treatment Guidelines for Ovarian Cancer as a Measure of Quality Care
- (2013) Robert E. Bristow et al. OBSTETRICS AND GYNECOLOGY
- Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer
- (2013) Laura J. Havrilesky et al. OBSTETRICS AND GYNECOLOGY
- Impact of Complete Cytoreduction Leaving No Gross Residual Disease Associated with Radical Cytoreductive Surgical Procedures on Survival in Advanced Ovarian Cancer
- (2012) Suk-Joon Chang et al. ANNALS OF SURGICAL ONCOLOGY
- The Changing View of High-Grade Serous Ovarian Cancer
- (2012) E. M. J. J. Berns et al. CANCER RESEARCH
- Converting Cancer Therapies into Cures: Lessons from Infectious Diseases
- (2012) Michael S. Glickman et al. CELL
- Hereditary ovarian cancer: Beyond the usual suspects
- (2012) Kathryn P. Pennington et al. GYNECOLOGIC ONCOLOGY
- Unraveling the two entities of endometrioid ovarian cancer: A single center clinical experience
- (2012) Giorgia Mangili et al. GYNECOLOGIC ONCOLOGY
- Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: A Gynecologic Oncology Group Study
- (2012) Bradley J. Monk et al. GYNECOLOGIC ONCOLOGY
- Diagnostic Value of Serum Human Epididymis Protein 4 (HE4) in Ovarian Carcinoma
- (2012) Li Wu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
- (2012) Kelly L. Bolton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome
- (2012) Christoph Engel et al. JOURNAL OF CLINICAL ONCOLOGY
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Resistance and Escape From Antiangiogenesis Therapy: Clinical Implications and Future Strategies
- (2012) Justin N. Bottsford-Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Adnexal Masses Suspected to Be Benign Treated with Laparoscopy
- (2012) Richard H. Demir et al. JSLS-Journal of the Society of Laparoendoscopic Surgeons
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
- (2012) John Farley et al. LANCET ONCOLOGY
- Revisiting the Complexity of the Ovarian Cancer Microenvironment--Clinical Implications for Treatment Strategies
- (2012) N. Musrap et al. MOLECULAR CANCER RESEARCH
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differing clinical impact ofBRCA1andBRCA2mutations in serous ovarian cancer
- (2012) Guoyan Liu et al. PHARMACOGENOMICS
- Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
- (2012) Stefan Bentink et al. PLoS One
- Endometrial and Ovarian Cancer in Lynch Syndrome
- (2012) Marta Crispens Clinics in Colon and Rectal Surgery
- Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations
- (2011) Ritu Salani et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
- (2011) David S.P. Tan et al. CLINICAL CANCER RESEARCH
- Ovarian cancer linked to lynch syndrome typically presents as early-onset, non-serous epithelial tumors
- (2011) Zohreh Ketabi et al. GYNECOLOGIC ONCOLOGY
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
- (2011) Shiyu Zhang et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
- (2011) Wei-Ting Hwang et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant Chemotherapy Cannot Be Regarded as Adequate Routine Therapy Strategy of Advanced Ovarian Cancer
- (2011) Andreas du Bois et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial
- (2011) Sandro Pignata et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
- (2011) T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RAD51 paralogs: Roles in DNA damage signalling, recombinational repair and tumorigenesis
- (2011) Natsuko Suwaki et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair
- (2010) P. J. O'Donovan et al. CARCINOGENESIS
- Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen
- (2010) Janet S. Hildebrand et al. INTERNATIONAL JOURNAL OF CANCER
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
- (2010) Susan M. Domchek JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
- (2010) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- Ovarian cancer: relevant therapy, not timing, is paramount
- (2010) Robert T Morris et al. LANCET
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Translating p53 into the clinic
- (2010) Chit Fang Cheok et al. Nature Reviews Clinical Oncology
- The Missing Voice of Patients in Drug-Safety Reporting
- (2010) Ethan Basch NEW ENGLAND JOURNAL OF MEDICINE
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers
- (2009) Chunqiao Tian et al. CANCER
- Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin
- (2009) Celeste Leigh Pearce et al. CANCER
- Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
- (2009) D. Etemadmoghadam et al. CLINICAL CANCER RESEARCH
- Serous papillary peritoneal carcinoma: Unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review
- (2009) George Pentheroudakis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Hormone Therapy and Ovarian Cancer
- (2009) Lina Steinrud Mørch JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
- (2009) Ursula A. Matulonis et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
- (2009) Michael A. Bookman et al. JOURNAL OF CLINICAL ONCOLOGY
- Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer
- (2009) Su-Jin Baek et al. Journal of Gynecologic Oncology
- Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
- (2009) Noriyuki Katsumata et al. LANCET
- Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses
- (2009) A. Sokalska et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Validation of FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort: A Gynecologic Oncology Group study
- (2008) Lari Wenzel et al. GYNECOLOGIC ONCOLOGY
- Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases
- (2008) Mariana C. Castells et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Serous Tubal Intraepithelial Carcinoma: Its Potential Role in Primary Peritoneal Serous Carcinoma and Serous Cancer Prevention
- (2008) Joseph W. Carlson et al. JOURNAL OF CLINICAL ONCOLOGY
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
- The genetics of the p53 pathway, apoptosis and cancer therapy
- (2008) Alexei Vazquez et al. NATURE REVIEWS DRUG DISCOVERY
- Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
- (2008) F. S. Hodi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized study of screening for ovarian cancer: a multicenter study in Japan
- (2007) H. KOBAYASHI et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started